Kowalski JL, Wink LK, Blankenship K, Habenicht CD, Erickson CA, Stigler KA, McDougle CJ. Paliperidone palmitate in a child with autistic disorder. J Child Adolesc Psychopharmacology. 2012.

Wink LK, Erickson CA, Stigler KA, McDougle CJ. Riluzole in autistic disorder. Journal of Child and Adolescent Psychopharmacology. 2012.

Erickson CA, Early M, Wink LK, McDougle CJ. An open-label naturalistic pilot study of acamprosate in youth with autistic disorder. Journal of Child Adolesc Psychopharmacology, 2012.

Erickson CA, Stigler KA, Wink LK, Mullett JE, Kohn A, Posey DJ, McDougle CJ. A prospective open-label study of aripiprazole in fragile X syndrome. Psychopharmacology. 2011 Feb 12.

Erickson CA, Stigler KA, Wink LK, Weng N, Weiler IJ, Greenough WT, McDougle CJ. Riluzole in Fragile X Syndrome. Brain Research. 2011;1380:264-70.

Wink LK, Erickson CA, Chambers JE, McDougle CJ. Comorbid intellectual disability and borderline personality disorder: A case series. Psychiatry. 2010;73(3):279-289.

Stigler KA, Erickson CA, Mullett JE, Posey DJ, McDougle CJ. Paliperidone for irritability in autistic disorder. J Child Adolesc Psychopharmacol. 2010 Feb;20(1):75-8.

Wink LK, Erickson CA, McDougle CJ. Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders. Current Treat Options Neurology. 2010;12:529-538.

Erickson CA, Mullett JE, McDougle CJ. Brief Report: Acamprosate in fragile X syndrome. J Autism Dev Disorder. 2010 Mar 6.